Vivien Azer of Cowen & Co. is extremely bullish about the prospects for cannabis companies.
New York (CNN Business) -- Marijuana is going mainstream and Wall Street has started to notice.
Recreational marijuana is now legal in Canada. And even though there is still a federal ban on pot in the United States, Washington has started to loosen some regulations on other products derived from cannabis, including hemp, following the recent passage of the Farm Bill.
Several states have also legalized recreational and medical marijuana.
That's why Vivien Azer of Cowen & Co. is extremely bullish about the prospects for cannabis companies.
Arkansas is split into eight zones, and the four highest scoring applicants in each may apply for a dispensary license.
With a 5-0 vote on Wednesday, the Arkansas Medical Marijuana Commission approved dispensary scoring recommendations from an outside consultant, which paves the way for licensing of the 32 facilities that will sell medical cannabis in the state.
Arkansas is split into eight zones, and the four highest scoring applicants in each may apply for a dispensary license. The state will mail "Intent to Award a License" letters to top-ranking applicants on Monday, Jan. 14. Once a company receives the letter, they have seven days to pay the required $15,000 licensing fee and post the $100,000 performance bond. Once this is done, the licenses will be awarded.
The bill now goes to the full Senate Medical Affairs Committee for consideration.
COLUMBIA — A panel of South Carolina legislators voted Thursday to advance a resolution urging Congress to open more research on medical uses for marijuana, taking another step toward loosening some of the state's attitudes toward the drug.
The measure implores federal lawmakers to "take immediate and additional steps to promote and actively pursue scientific research and testing into the potential use of cannabis to treat other medical conditions and illness by removing the federal statutory and regulatory barriers that prevent these scientific endeavors." It now goes to the full Senate Medical Affairs Committee for consideration.
MBI-110 Biofungicide and Haven Sunprotectant have been approved by the appropriate government agencies.
DAVIS, Calif. – Jan. 9, 2019 – PRESS RELEASE – Marrone Bio Innovations Inc., a smart biopesticide and plant health solutions company, has announced that two of its products have been approved for sale in Canada by the appropriate government agencies. MBI-110 Biofungicide, (marketed in the U.S. as StargusÒ for specialty crops) was approved by the Pest Management Regulatory Authority (PMRA). HavenÒ Sunprotectant was approved by the Canadian Food Inspection Agency (CFIA).
According to Phillips McDougall, the Canadian pesticide market totaled $1.7 billion in 2016 and is expected to grow at a CAGR of 2.3 percent to $1.9 billion in 2021. While market figures for the $2-3 billion global biostimulant market do not break out Canada, growth of biostimulants in Canada, which includes products like Haven, in Canada follows the growth trends of the rest of the world at a 10-12 percent CAGR.
The active ingredient in Stargus is a new strain of Bacillus amyloliquefaciens, a bacterium isolated by MBI scientists from a soil sample in northern California. While this type of Bacillus is common in soil, and other biological products contain the same species, MBI's discovery is unique in its high performance on downy mildews, white molds,Fusarium and Botrytis gray mold, which are particularly difficult to control with both biologicals and chemicals. The bacteria in Stargus work by colonizing plant root hairs, leaves and other plant surfaces, thereby preventing establishment of fungal and bacterial pathogens. The Stargus bacteria also produce natural compounds that inhibit bacterial and fungal growth and spore germination. Further, the bacteria trigger immune responses in the plant to ward off diseases and increase growth and yield, creating a healthier and stronger plant. In Canada, the approved label for Stargus is for the control or suppression of various diseases on cucurbits, legume vegetables, potatoes, grapevines, canola and sunflowers. MBI holds two U.S. patents on the novel strain in the biofungicide product.
The active ingredient in Haven is an extract derived from coconut. Use of Haven helps treated plants maintain lower leaf temperatures and reduces heat stress on the crops, resulting in higher yields and quality. When two-to-four applications are sprayed on crops–generally starting at bloom, shortly after bloom, or at early fruit/nut set–in commercial usage, grower demos and third-party trials, Haven has shown to reduce sun damage and increase yields and quality for certain apple varieties, almonds, walnuts, soft berries, citrus, grapes and tomatoes. Haven also has increased yields of corn, wheat and turf grass. The Canadian label is approved for tree crops such as apples pears, cherries, plums and peaches, nuts including filberts and walnuts, fruiting vegetables such as tomato and pepper. One of the most promising uses for Haven in Canada is apples, because Haven helps to reduce bitter pit, which causes dark, ugly spots.
Marrone Bio Innovations offers a broad suite of product solutions in cannabis. It is always advised that the grower check with their local agricultural authority for information on use of products.
The use of Haven Sun Protectant is available in the United States. Haven helps treated plants maintain lower leaf temperatures and reduces heat stress, resulting in higher yields and quality. View the U.S. Haven Label.
Stargus Biofungicide, the brand name of MBI-110 EP, is registered in the U.S. and Marrone anticipates a Stargus CG product for cannabis growers in the U.S. in the future.
Available now for use in cannabis, MBI produces Regalia CG Biofungicide, that is registered in most states, including California. Use on cannabis in California is not in conflict with the label. Regalia CG Biofungicide isan OMRI listed plant extract based fungicide. Regalia CG stimulates the plant's innate ability to fight diseases and delivers better yield and improved harvest quality in cannabis. It also offers preventative activity and early control of yield-robbing diseases. View the Regalia CG Label.
Grandevo CG Bioinsecticide is an OMRI listed microbial-based insecticide and miticide. Grandevo CG contains several active compounds that, when applied early in the crop cycle, repel, stop feeding, reduce reproduction and induce mortality to prevent the development of damaging populations of sucking and chewing insects, flies and mites. The active ingredient in Grandevo CG, is "exempt from a residue tolerance" and is a low risk biopesticide that does not have a "WARNING" signal word on its product label. Use on cannabis in California is not in conflict with the label. Grandevo CG is available nationwide today. View the Grandevo CG Label.
Venerate CG Bioinsecticide is an OMRI listed microbial-based insecticide, miticide and acaricide featuring multiple modes of action and are effective against a wide variety of chewing and sucking insects, aphids and mites. Venerate CG products can be applied during the entire season. The active ingredient in Venerate CG is "exempt from a residue tolerance" and is a low risk biopesticide that does not have a "WARNING" signal word on its product label. Venerate CG is available in most states today, with the California registration expected in Spring 2019. View the Venerate CG Label.
Please find additional product information and label updates at www.MarroneBio.com.